Healthtech Startups
15,468 companies tagged Healthtech, with their investors and founders.
Tennr provides an AI-powered platform for pre-visit patient processing and healthcare referral management that integrates with EHR systems and reduces patient delays and denials. The platform serves healthcare practices and referral networks by automating document processing and payor guideline compliance to streamline patient intake workflows.
9 investors
Tiny Health offers at-home gut and vaginal microbiome test kits with age-specific, evidence-based reports that recommend diet, supplement, and lifestyle changes. It targets families across life stages—from preconception and pregnancy through infancy, childhood, and adulthood—to detect microbiome imbalances and support prevention of conditions like eczema, allergies, and GI issues.
9 investors
SelfWrap develops bioabsorbable wrap materials for vascular grafts that conform to individual patient anatomy and are designed to be absorbed by the body, unlike alloy-based alternatives. The company is developing the product for coronary and peripheral bypass grafting applications.
9 investors
Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease. The company applies frontier AI techniques to drug discovery for life sciences and pharmaceutical development.
9 investors
Verona Pharma develops treatments for chronic lung conditions. As of October 2025, it and its subsidiaries are part of Merck & Co., Inc.
9 investors
Wagmo offers employee benefits including wellness programs, insurance products, and veterinary telehealth services. The platform serves as an employee benefit activation system for employers.
9 investors
Weave offers team communication and collaboration tools for healthcare practices, including messaging, scheduling, and patient management features accessible from desktop and mobile apps.
9 investors
xCures builds an AI platform that assembles and structures fragmented medical records into organized, decision-ready clinical data for healthcare organizations. The platform serves providers, clinicians, and healthcare systems across all therapeutic areas to improve care coordination and decision-making.
9 investors
Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment. Its approach aims to achieve durable efficacy for cancer patients while avoiding the severe systemic side effects of conventional immuno-oncology agents.
9 investors
Akido Labs develops an AI operating system designed for healthcare that leverages machine learning to enable personalized medical diagnostics and care coordination at scale. The platform aims to make high-quality healthcare accessible regardless of financial means or geography.
8 investors
Alan provides health insurance, provident insurance (prévoyance) and prevention services for self-employed individuals, companies of all sizes, retirees, and public-sector workers, combining coverage with a digital app for reimbursements, telehealth consultations (Clinique Alan), and wellness features. The company operates in France and focuses on simplifying insurance administration for employers while promoting employee physical and mental well-being.
8 investors
Alchemy 43 offers aesthetic and self-care treatments, providing appointment-based cosmetic services to consumers.
8 investors
Amogy develops patented ammonia cracking technology that converts ammonia into electric power for hydrogen fuel cells and engines, targeting decarbonization of heavy industries including transportation and maritime. The company offers modular ammonia-to-power systems and high-efficiency catalysts as alternatives to diesel and hydrogen fuel solutions.
8 investors
ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers. Its pipeline centers on its lead candidate firmonertinib (formerly furmonertinib) and novel oncology therapeutics such as next-generation antibody drug conjugates.
8 investors
Automata provides lab automation and data management tools, enabling researchers and technicians to generate accurate data at scale through intuitive workflow creation.
8 investors
Avaamo builds a conversational AI platform for enterprise that deploys autonomous agents across healthcare, customer support, and employee support operations. The platform executes end-to-end workflows in hospitals, contact centers, and HR departments to reduce manual administrative work.
8 investors
Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies. The company operates in the biotech and respiratory drug development space.
8 investors
Bioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation. It applies machine learning to areas such as computational pathology, genomics, and drug discovery.
8 investors
C16 Biosciences produces high-value lipid ingredients using fermentation of naturally occurring microorganisms for manufacturers of beauty, personal care, home care, and food products. The company's biomanufacturing platform enables sustainable production with 250x greater land efficiency than traditional ingredient sources.
8 investors
CalmWave integrates hospital data — alarms, vital signs, medications, and EHR records — into a unified real-time platform that uses data science and AI to deliver operational insights and reduce non-actionable alarms. The product is aimed at hospitals and care teams to improve patient safety, reduce alarm fatigue, and streamline clinical workflows.
8 investors
Causaly builds an agentic AI platform for life sciences R&D that retrieves and reasons over scientific evidence, using a scientific knowledge graph and specialized AI agents to support target identification, indication discovery, and regulatory evidence validation. It serves biomedical and pharmaceutical enterprises across the R&D pipeline, from early research through clinical development and post-market.
8 investors
Centaur.ai combines human medical professionals' assessments with AI algorithms to improve diagnostic accuracy for skin lesion evaluation and cancer detection. The platform weights opinions based on performance metrics to achieve results superior to either doctors or AI alone.
8 investors
A company offering personalized supplement recommendations for women through a quiz-based matching system covering fertility, prenatal, postpartum, and hormone balance categories.
8 investors
Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies. The company serves cancer patients and their caregivers globally.
8 investors